The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 06, 2026 for Aayush Agrawal, ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma promoter Aayush Agrawal (trustee of Aayush Agrawal Trust) released a pledge on 1,49,000 shares (0.12% of total share capital) on 4 February 2026. The pledge was held with RBL Bank Limited, and the reason cited is a reduction in the bank guarantee amount. After this release, the trust's encumbered shares stand at 80,99,407 shares (6.48%), down from 82,48,407 shares (6.60%) earlier. The trust's overall promoter holding remains at 1,41,12,924 shares (11.30%) of the company.
This is a routine, small pledge release (less than 0.15% of share capital) due to a bank guarantee reduction, not a stress signal. Shareholders are unlikely to see any meaningful impact on the stock price from this disclosure.